Please login to the form below

Not currently logged in
Email:
Password:

90Ten Healthcare boosts PR team

Claire Long, Amy O’Connor and Danielle Guildford-Sharp join

90Ten Healthcare Claire LongHealthcare consultancy 90Ten Healthcare has boosted its public relations team with the appointments of Claire Long, Amy O'Connor and Danielle Guildford-Sharp.

Long (pictured right) becomes associate director, moving to 90Ten after five years at Ketchum as a practice director in its healthcare team.

She brings further experience working with international and UK pharmaceutical accounts from Sydney, Australia-based Cube, and UK-based FTI Consulting.

90Ten Healthcare Amy O'ConnorMeanwhile, O'Connor (pictured left) and Guildford-Sharp (pictured below) join the London agency as account managers.

Also moving from Ketchum, O'Conner most recently served as an account manager having first joined as an account coordinator in 2013, while Guildford-Sharp joins after five years at Liberation Unlimited where she was latterly an account manager.

90Ten Healthcare Danielle Guildford-SharpPeter Impey, 90Ten's director of PR, said: “We are delighted by these appointments that will bolster 90Ten's team with some of the best talent in the industry.

“Our PR division is going from strength to strength and Claire, Amy and Danielle will play an important role in ensuring we continue to deliver exceptional work for our clients that truly changes behaviour.”

8th December 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...